{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:52:51Z","timestamp":1790704371039,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00520-025-09218-x","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T05:48:27Z","timestamp":1738993707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The impact of cannabis on immune checkpoint inhibitor therapy: a systematic review of immunomodulatory effects of cannabis in patients with and without cancer"],"prefix":"10.1007","volume":"33","author":[{"given":"Caroline","family":"Behling-Hess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Simonson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talya","family":"Salz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fleege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Zylla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"9218_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1200\/EDBK_156572","volume":"36","author":"V Velcheti","year":"2016","unstructured":"Velcheti V, Schalper K (2016) Basic overview of current immunotherapy approaches in cancer. Am Soc Clin Oncol Educ Book 36:298\u2013308","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"6441","key":"9218_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365(6441):61\u201365","journal-title":"Nature"},{"issue":"1","key":"9218_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","volume":"232","author":"S Gali\u00e8gue","year":"1995","unstructured":"Gali\u00e8gue S, Mary S, Marchand J, Dussossoy D, Carri\u00e8re D, Carayon P et al (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232(1):54\u201361","journal-title":"Eur J Biochem"},{"issue":"1","key":"9218_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/ijms22010263","volume":"22","author":"P \u015aledzi\u0144ski","year":"2020","unstructured":"\u015aledzi\u0144ski P, Nowak-Terpi\u0142owska A, Zeyland J (2020) Cannabinoids in medicine: cancer, immunity, and microbial diseases. Int J Mol Sci 22(1):263","journal-title":"Int J Mol Sci"},{"issue":"2","key":"9218_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s11481-015-9603-3","volume":"10","author":"TK Eisenstein","year":"2015","unstructured":"Eisenstein TK (2015) Effects of cannabinoids on T-cell function and resistance to infection. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 10(2):204\u2013216","journal-title":"J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol"},{"issue":"1","key":"9218_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1089\/can.2018.0073","volume":"5","author":"JM Nichols","year":"2020","unstructured":"Nichols JM, Kaplan BLF (2020) Immune responses regulated by cannabidiol. Cannabis Cannabinoid Res 5(1):12\u201331","journal-title":"Cannabis Cannabinoid Res"},{"issue":"9","key":"9218_CR7","first-page":"545","volume":"31","author":"T Salz","year":"2023","unstructured":"Salz T, Mishra Meza A, Chino F, Mao JJ, Raghunathan N, Jinna S et al (2023) Cannabis use among recently treated cancer patients: perceptions and experiences. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 31(9):545","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"66","key":"9218_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/jncimonographs\/lgae029","volume":"2024","author":"GL Ellison","year":"2024","unstructured":"Ellison GL, Helzlsouer KJ, Rosenfield SM, Kim Y, Ashare RL, Blaes AH et al (2024) Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers. JNCI Monogr 2024(66):202\u2013217","journal-title":"JNCI Monogr"},{"issue":"22","key":"9218_CR9","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1002\/cncr.30879","volume":"123","author":"SA Pergam","year":"2017","unstructured":"Pergam SA, Woodfield MC, Lee CM, Cheng G, Baker KK, Marquis SR et al (2017) Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer 123(22):4488\u20134497","journal-title":"Cancer"},{"issue":"4","key":"9218_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1634\/theoncologist.2018-0383","volume":"24","author":"T Taha","year":"2019","unstructured":"Taha T, Meiri D, Talhamy S, Wollner M, Peer A, Bar-Sela G (2019) Cannabis impacts tumor response rate to nivolumab in patients with advanced malignancies. Oncologist 24(4):549\u2013554","journal-title":"Oncologist"},{"issue":"9","key":"9218_CR11","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3390\/cancers12092447","volume":"12","author":"G Bar-Sela","year":"2020","unstructured":"Bar-Sela G, Cohen I, Campisi-Pinto S, Lewitus GM, Oz-Ari L, Jehassi A et al (2020) Cannabis consumption used by cancer patients during immunotherapy correlates with poor clinical outcome. Cancers 12(9):2447","journal-title":"Cancers"},{"issue":"180","key":"9218_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejca.2022.11.022","volume":"1","author":"B Waissengrin","year":"2023","unstructured":"Waissengrin B, Leshem Y, Taya M, Meiri D, Merimsky O, Shamai S et al (2023) The use of medical cannabis concomitantly with immune checkpoint inhibitors in non-small cell lung cancer: a sigh of relief? Eur J Cancer 1(180):52\u201361","journal-title":"Eur J Cancer"},{"issue":"15_suppl","key":"9218_CR13","doi-asserted-by":"publisher","first-page":"e15064","DOI":"10.1200\/JCO.2020.38.15_suppl.e15064","volume":"38","author":"A Biedny","year":"2020","unstructured":"Biedny A, Szpunar S, Abdalla A, Kafri Z, Hadid TH (2020) The effect of concomitant cannabinoids during immune checkpoint inhibitor treatment of advanced stage malignancy. J Clin Oncol. 38(15_suppl):e15064\u2013e15064","journal-title":"J Clin Oncol."},{"issue":"4","key":"9218_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.7326\/0003-4819-139-4-200308190-00008","volume":"139","author":"DI Abrams","year":"2003","unstructured":"Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT et al (2003) Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med 139(4):258\u2013266","journal-title":"Ann Intern Med"},{"key":"9218_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.drugalcdep.2014.11.017","volume":"1","author":"O Alshaarawy","year":"2015","unstructured":"Alshaarawy O, Anthony JC (2015) Cannabis smoking and serum C-reactive protein: a quantile regressions approach based on NHANES 2005\u20132010. Drug Alcohol Depend 1:203\u2013207","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"9218_CR16","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.amjmed.2019.04.045","volume":"132","author":"O Alshaarawy","year":"2019","unstructured":"Alshaarawy O, Sidney S, Auer R, Green D, Soliman EZ, Goff DC et al (2019) Cannabis use and markers of systemic inflammation the coronary artery risk development in young adults study. Am J Med 132(11):1327-1334.e1","journal-title":"Am J Med"},{"key":"9218_CR17","doi-asserted-by":"publisher","first-page":"110326","DOI":"10.1016\/j.jpsychores.2020.110326","volume":"141","author":"AM Andersen","year":"2021","unstructured":"Andersen AM, Lei MK, Beach SRH, Philibert RA (2021) Inflammatory biomarker relationships with helper T cell GPR15 expression and cannabis and tobacco smoking. J Psychosom Res 141:110326","journal-title":"J Psychosom Res"},{"issue":"S1","key":"9218_CR18","doi-asserted-by":"publisher","first-page":"82S","DOI":"10.1002\/j.1552-4604.2002.tb06007.x","volume":"42","author":"BM Bredt","year":"2002","unstructured":"Bredt BM, Higuera-Alhino D, Shade SB, Hebert SJ, McCune JM, Abrams DI (2002) Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients. J Clin Pharmacol 42(S1):82S-89S","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"9218_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.drugalcdep.2013.08.027","volume":"133","author":"EJ Costello","year":"2013","unstructured":"Costello EJ, Copeland WE, Shanahan L, Worthman CM, Angold A (2013) C-Reactive Protein and substance use disorders in adolescence and early adulthood: a prospective analysis. Drug Alcohol Depend 133(2):712\u2013717","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"9218_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1089\/can.2021.0093","volume":"7","author":"JAS Crippa","year":"2022","unstructured":"Crippa JAS, Pacheco JC, Zuardi AW, Guimar\u00e3es FS, Campos AC, de Os\u00f3rio F, L, et al (2022) Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE Study): a randomized, double-blind, placebo-controlled clinical trial. Cannabis Cannabinoid Res 7(5):658\u2013669","journal-title":"Cannabis Cannabinoid Res"},{"key":"9218_CR21","doi-asserted-by":"publisher","unstructured":"EL-Gohary M, Eid M. Effect of cannabinoid ingestion (in the form of bhang) on the immune system of high school and university students [Internet]. [cited 2023 Dec 30]. Available from: https:\/\/doi.org\/10.1191\/0960327104ht426oa?src=getftr","DOI":"10.1191\/0960327104ht426oa?src=getftr"},{"issue":"5","key":"9218_CR22","doi-asserted-by":"publisher","first-page":"e809","DOI":"10.1212\/NXI.0000000000000809","volume":"7","author":"RJ Ellis","year":"2020","unstructured":"Ellis RJ, Peterson SN, Li Y, Schrier R, Iudicello J, Letendre S et al (2020) Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and blood. Neurol Neuroimmunol Neuroinflammation 7(5):e809","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"10","key":"9218_CR23","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1111\/ctr.12828","volume":"30","author":"G Greenan","year":"2016","unstructured":"Greenan G, Ahmad SB, Anders MG, Leeser A, Bromberg JS, Niederhaus SV (2016) Recreational marijuana use is not associated with worse outcomes after renal transplantation. Clin Transplant 30(10):1340\u20131346","journal-title":"Clin Transplant"},{"issue":"4","key":"9218_CR24","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/ibd\/izy002","volume":"24","author":"PM Irving","year":"2018","unstructured":"Irving PM, Iqbal T, Nwokolo C, Subramanian S, Bloom S, Prasad N et al (2018) A randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis. Inflamm Bowel Dis 24(4):714\u2013724","journal-title":"Inflamm Bowel Dis"},{"issue":"23","key":"9218_CR25","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1001\/jama.1989.03420230078030","volume":"261","author":"RA Kaslow","year":"1989","unstructured":"Kaslow RA, Blackwelder WC, Ostrow DG, Yerg D, Palenicek J, Coulson AH et al (1989) No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals. A report from the Multicenter AIDS Cohort Study. JAMA 261(23):3424\u20133429","journal-title":"JAMA"},{"issue":"3","key":"9218_CR26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1365-2249.2005.02803.x","volume":"140","author":"S Katona","year":"2005","unstructured":"Katona S, Kaminski E, Sanders H, Zajicek J (2005) Cannabinoid influence on cytokine profile in multiple sclerosis. Clin Exp Immunol 140(3):580\u2013585","journal-title":"Clin Exp Immunol"},{"issue":"140","key":"9218_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.drugalcdep.2014.04.011","volume":"1","author":"L Keen","year":"2014","unstructured":"Keen L, Pereira D, Latimer W (2014) Self-reported lifetime marijuana use and interleukin-6 levels in middle-aged African Americans. Drug Alcohol Depend 1(140):156\u2013160","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20132","key":"9218_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0165-5728(03)00045-6","volume":"137","author":"J Killestein","year":"2003","unstructured":"Killestein J, Hoogervorst ELJ, Reif M, Blauw B, Smits M, Uitdehaag BMJ et al (2003) Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis. J Neuroimmunol 137(1\u20132):140\u2013143","journal-title":"J Neuroimmunol"},{"issue":"3","key":"9218_CR29","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41423-020-0437-4","volume":"18","author":"K Kotschenreuther","year":"2021","unstructured":"Kotschenreuther K, Waqu\u00e9 I, Yan S, Meyer A, Haak T, von Tresckow J et al (2021) Cannabinoids drive Th17 cell differentiation in patients with rheumatic autoimmune diseases. Cell Mol Immunol 18(3):764\u2013766","journal-title":"Cell Mol Immunol"},{"key":"9218_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.drugpo.2017.02.009","volume":"42","author":"S Lake","year":"2017","unstructured":"Lake S, Kerr T, Capler R, Shoveller J, Montaner J, Milloy MJ (2017) High-Intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver. Canada Int J Drug Policy 42:63\u201370","journal-title":"Canada Int J Drug Policy"},{"issue":"4241","key":"9218_CR31","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1265484","volume":"192","author":"RJ Lau","year":"1976","unstructured":"Lau RJ, Tubergen DG, Barr M, Domino EF, Benowitz N, Jones RT (1976) Phytohemagglutinin-induced lymphocyte transformation in humans receiving \u03949-tetrahydrocannabinol. Science 192(4241):805\u2013807","journal-title":"Science"},{"issue":"12","key":"9218_CR32","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/cid\/cix1116","volume":"66","author":"JA Manuzak","year":"2018","unstructured":"Manuzak JA, Gott TM, Kirkwood JS, Coronado E, Hensley-McBain T, Miller C et al (2018) Heavy cannabis use associated with reduction in activated and inflammatory immune cell frequencies in antiretroviral therapy\u2013treated human immunodeficiency virus\u2013infected individuals. Clin Infect Dis Off Publ Infect Dis Soc Am 66(12):1872\u20131882","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"2","key":"9218_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/dar.12398","volume":"36","author":"F Marcellin","year":"2017","unstructured":"Marcellin F, Lions C, Rosenthal E, Roux P, Sogni P, Wittkop L et al (2017) No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort). Drug Alcohol Rev 36(2):227\u2013238","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"9218_CR34","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s10620-019-05756-7","volume":"65","author":"K Mathur","year":"2020","unstructured":"Mathur K, Vuppalanchi V, Gelow K, Vuppalanchi R, Lammert C (2020) Cannabidiol (CBD) consumption and perceived impact on extrahepatic symptoms in patients with autoimmune hepatitis. Dig Dis Sci 65(1):322\u2013328","journal-title":"Dig Dis Sci"},{"issue":"11","key":"9218_CR35","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/ecco-jcc\/jjab069","volume":"15","author":"T Naftali","year":"2021","unstructured":"Naftali T, Bar-Lev Schleider L, Almog S, Meiri D, Konikoff FM (2021) Oral CBD-rich cannabis induces clinical but not endoscopic response in patients with Crohn\u2019s disease, a randomised controlled trial. J Crohns Colitis 15(11):1799\u20131806","journal-title":"J Crohns Colitis"},{"issue":"2","key":"9218_CR36","doi-asserted-by":"publisher","first-page":"e0246871","DOI":"10.1371\/journal.pone.0246871","volume":"16","author":"T Naftali","year":"2021","unstructured":"Naftali T, Bar-Lev Schleider L, Scklerovsky Benjaminov F, Konikoff FM, Matalon ST, Ringel Y (2021) Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: a randomized controlled trial. PLoS ONE 16(2):e0246871","journal-title":"PLoS ONE"},{"issue":"8","key":"9218_CR37","first-page":"455","volume":"13","author":"T Naftali","year":"2011","unstructured":"Naftali T, Lev LB, Yablecovitch D, Half E, Konikoff FM (2011) Treatment of Crohn\u2019s disease with cannabis: an observational study. Isr Med Assoc J IMAJ 13(8):455\u2013458","journal-title":"Isr Med Assoc J IMAJ"},{"issue":"6","key":"9218_CR38","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s10620-017-4540-z","volume":"62","author":"T Naftali","year":"2017","unstructured":"Naftali T, Mechulam R, Marii A, Gabay G, Stein A, Bronshtain M et al (2017) Low-dose cannabidiol is safe but not effective in the treatment for Crohn\u2019s disease, a randomized controlled trial. Dig Dis Sci 62(6):1615\u20131620","journal-title":"Dig Dis Sci"},{"issue":"4123","key":"9218_CR39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1126\/science.183.4123.419","volume":"183","author":"GG Nahas","year":"1974","unstructured":"Nahas GG, Suciu-Foca N, Armand JP, Morishima A (1974) Inhibition of cellular mediated immunity in marihuana smokers. Science 183(4123):419\u2013420","journal-title":"Science"},{"issue":"15","key":"9218_CR40","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1001\/jama.289.15.1929-a","volume":"289","author":"R Pacifici","year":"2003","unstructured":"Pacifici R, Zuccaro P, Pichini S, Roset PN, Poudevida S, Farr\u00e9 M et al (2003) Modulation of the immune system in cannabis users. JAMA 289(15):1929\u20131931","journal-title":"JAMA"},{"issue":"4","key":"9218_CR41","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0091-6749(76)90192-5","volume":"58","author":"GS Rachelefsky","year":"1976","unstructured":"Rachelefsky GS, Opelz G, Mickey MR, Lessin P, Kiuchi M, Silverstein MJ et al (1976) Intact humoral and cell-mediated immunity in chronic marijuana smoking. J Allergy Clin Immunol 58(4):483\u2013490","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9218_CR42","doi-asserted-by":"publisher","first-page":"e000494","DOI":"10.1136\/bmjopen-2011-000494","volume":"2","author":"TB Rajavashisth","year":"2012","unstructured":"Rajavashisth TB, Shaheen M, Norris KC, Pan D, Sinha SK, Ortega J et al (2012) Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III. BMJ Open 2(1):e000494","journal-title":"BMJ Open"},{"issue":"4","key":"9218_CR43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/QAD.0000000000001704","volume":"32","author":"MD Rizzo","year":"2018","unstructured":"Rizzo MD, Crawford RB, Henriquez JE, Aldhamen Y, Gulick P, Amalfitano A et al (2018) HIV-infected cannabis users have lower circulating CD16+ monocytes and IP-10 levels compared to non-using HIV patients. AIDS Lond Engl 32(4):419\u2013429","journal-title":"AIDS Lond Engl"},{"issue":"5","key":"9218_CR44","first-page":"734","volume":"25","author":"P Serrano Rodriguez","year":"2019","unstructured":"Serrano Rodriguez P, Strassle PD, Barritt AS, Watkins R, Gerber DA, Hayashi PH et al (2019) Marijuana consumption in liver transplant recipients. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc 25(5):734\u2013740","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"issue":"5","key":"9218_CR45","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10787-014-0214-z","volume":"22","author":"M Sexton","year":"2014","unstructured":"Sexton M, Cudaback E, Abdullah RA, Finnell J, Mischley LK, Rozga M et al (2014) Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters. Inflammopharmacology 22(5):295\u2013303","journal-title":"Inflammopharmacology"},{"issue":"3","key":"9218_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10787-012-0133-9","volume":"21","author":"M Sexton","year":"2013","unstructured":"Sexton M, Silvestroni A, M\u00f6ller T, Stella N (2013) Differential migratory properties of monocytes isolated from human subjects na\u00efve and non-na\u00efve to cannabis. Inflammopharmacology 21(3):253\u2013259","journal-title":"Inflammopharmacology"},{"issue":"3","key":"9218_CR47","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/01.MIB.0000440982.79036.d6","volume":"20","author":"M Storr","year":"2014","unstructured":"Storr M, Devlin S, Kaplan GG, Panaccione R, Andrews CN (2014) Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn\u2019s disease. Inflamm Bowel Dis 20(3):472\u2013480","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"9218_CR48","first-page":"5228","volume":"15","author":"R Wang","year":"2023","unstructured":"Wang R, Trigo JM, Le Foll B (2023) Effects of sub-chronic nabiximols on biological markers of individuals undergoing a clinical trial for the treatment of cannabis use disorder. Am J Transl Res 15(8):5228\u20135238","journal-title":"Am J Transl Res"},{"key":"9218_CR49","doi-asserted-by":"publisher","unstructured":"White SC, Brin SC, Janicki BW. Mitogen-induced blastogenic responses of lymphocytes from marihuana smokers | Science [Internet]. Available from: https:\/\/doi.org\/10.1126\/science.1078732","DOI":"10.1126\/science.1078732"},{"issue":"10","key":"9218_CR50","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.bbmt.2015.05.018","volume":"21","author":"M Yeshurun","year":"2015","unstructured":"Yeshurun M, Shpilberg O, Herscovici C, Shargian L, Dreyer J, Peck A et al (2015) Cannabidiol for the prevention of graft-versus-host-disease after allogeneic hematopoietic cell transplantation: results of a phase II study. Biol Blood Marrow Transplant 21(10):1770\u20131775","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"9218_CR51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/healthcare11010116","volume":"11","author":"M Cani","year":"2022","unstructured":"Cani M, Bironzo P, Garetto F, Buffoni L, Cotogni P (2022) Immune checkpoint inhibitors and opioids in patients with solid tumours: is their association safe? A systematic literature review. Healthcare 11(1):116","journal-title":"Healthcare"},{"issue":"1","key":"9218_CR52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12967-021-02784-8","volume":"19","author":"A Botticelli","year":"2021","unstructured":"Botticelli A, Cirillo A, Pomati G, Cerbelli B, Scagnoli S, Roberto M et al (2021) The role of opioids in cancer response to immunotherapy. J Transl Med 19(1):119","journal-title":"J Transl Med"},{"issue":"6","key":"9218_CR53","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s00432-022-04513-0","volume":"149","author":"M Ju","year":"2023","unstructured":"Ju M, Gao Z, Liu X, Zhou H, Wang R, Zheng C et al (2023) The negative impact of opioids on cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. J Cancer Res Clin Oncol 149(6):2699\u20132708","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"9218_CR54","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cllc.2022.12.013","volume":"24","author":"NT Sebastian","year":"2023","unstructured":"Sebastian NT, Stokes WA, Behera M, Jiang R, Gutman DA, Huang Z et al (2023) the association of improved overall survival with NSAIDs in non\u2013small cell lung cancer patients receiving immune checkpoint inhibitors. Clin Lung Cancer 24(3):287\u2013294","journal-title":"Clin Lung Cancer"},{"issue":"14","key":"9218_CR55","doi-asserted-by":"publisher","first-page":"1125876","DOI":"10.3389\/fimmu.2023.1125876","volume":"10","author":"R Geng","year":"2023","unstructured":"Geng R, Tang H, You T, Xu X, Li S, Li Z et al (2023) Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1\/PD-L1 inhibitors in cancer patients. Front Immunol 10(14):1125876","journal-title":"Front Immunol"},{"key":"9218_CR56","doi-asserted-by":"publisher","unstructured":"Wang M, Zhai X, Li J, Guan J, Xu S, Li Y, et al. The role of cytokines in predicting the response and adverse events related to immune checkpoint inhibitors. Front Immunol [Internet]. 2021 Jul 22 [cited 2024 May 19];12. Available from: https:\/\/doi.org\/10.3389\/fimmu.2021.670391\/full","DOI":"10.3389\/fimmu.2021.670391\/full"},{"issue":"5","key":"9218_CR57","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/curroncol29050247","volume":"29","author":"Y Shiravand","year":"2022","unstructured":"Shiravand Y, Khodadadi F, Kashani SMA, Hosseini-Fard SR, Hosseini S, Sadeghirad H et al (2022) Immune checkpoint inhibitors in cancer therapy. Curr Oncol 29(5):3044\u20133060","journal-title":"Curr Oncol"},{"issue":"Suppl 2","key":"9218_CR58","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-2036.1996.22164025.x","volume":"10","author":"R Brattsand","year":"1996","unstructured":"Brattsand R, Linden M (1996) Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther. 10(Suppl 2):81\u201390 (discussion 91\u201392)","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"9218_CR59","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1200\/OP.22.00080","volume":"18","author":"B Worster","year":"2022","unstructured":"Worster B, Hajjar ER, Handley N (2022) Cannabis use in patients with cancer: a clinical review. JCO Oncol Pract 18(11):743\u2013749","journal-title":"JCO Oncol Pract"},{"issue":"19","key":"9218_CR60","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S0024-3205(97)00113-6","volume":"60","author":"C S\u00e1nchez","year":"1997","unstructured":"S\u00e1nchez C, Velasco G, Guzm\u00e1n M (1997) Metabolic stimulation of mouse spleen lymphocytes by low doses of 9-tetrahydrocannabinol. Life Sci 60(19):1709\u20131717","journal-title":"Life Sci"},{"issue":"2","key":"9218_CR61","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0014-2999(97)01007-8","volume":"330","author":"EV Berdyshev","year":"1997","unstructured":"Berdyshev EV, Boichot E, Germain N, Allain N, Anger JP, Lagente V (1997) Influence of fatty acid ethanolamides and \u03949-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. Eur J Pharmacol 330(2):231\u2013240","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"9218_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jneuroim.2005.04.023","volume":"166","author":"JL Croxford","year":"2005","unstructured":"Croxford JL, Yamamura T (2005) Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? J Neuroimmunol 166(1):3\u201318","journal-title":"J Neuroimmunol"},{"issue":"7","key":"9218_CR63","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1111\/j.1476-5381.2010.01176.x","volume":"163","author":"LA Parker","year":"2011","unstructured":"Parker LA, Rock EM, Limebeer CL (2011) Regulation of nausea and vomiting by cannabinoids. Br J Pharmacol 163(7):1411\u20131422","journal-title":"Br J Pharmacol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09218-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09218-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09218-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T01:36:10Z","timestamp":1742002570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09218-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["9218"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09218-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}